Get the latest Science News and Discoveries

UMSOM researchers identify safety of a potential new treatment to manage complications from sickle cell disease - EurekAlert

A drug approved to treat pulmonary arterial hypertension may be effective at managing hypertension and end-organ damage in patients with sickle cell disease, according to a new study published in&nbsp;<em>Lancet Haematology</em>. An early phase randomized clinical trial involving 130 patients with sickle cell disease found that the drug, called riociguat, was found to be safe to use and well tolerated in these patients and significantly improved their blood pressure. Preliminary efficacy data suggested the medication might improve heart function.

None

Get the Android app